FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileElixinol Wellness Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Discussion
EXL.AX
Elixinol Wellness Limited Stock AnalysisComprehensive stock analysis for Elixinol Wellness Limited (EXL.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisEXL.AX
EXL.AX
Elixinol Wellness Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Discussion
EXL.AX
  1. Home
  2. Stocks
  3. Elixinol Wellness Limited

Elixinol Wellness Limited

🇦🇺EXL.AX•ASX

Elixinol Wellness Limited

🇦🇺EXL.AX•ASX

Your view on EXL.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Elixinol Wellness Limited

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Natalie Butler
Headquarters
51 - 53 Riversdale Road, Newtown, VIC, AU
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Natalie Butler
Headquarters
51 - 53 Riversdale Road, Newtown, VIC, AU
Description

Elixinol Wellness Limited, an entity established in 2017 and headquartered in Sydney, Australia, operates internationally through its subsidiaries. The company is primarily involved in the manufacturing and global distribution of a wide array of hemp-derived products, encompassing nutraceuticals, cosmetics, and various food items.

These products are marketed under its distinct brands, Elixinol and Hemp Foods Australia, reaching consumers across the Americas, Europe, and Australia. Its extensive product range features hemp-derived cannabidiol (CBD) items, food products, dietary supplements, and topical skincare solutions.

Notably, the company transitioned to its current name in May 2021, having previously been known as Elixinol Global Limited.

FRC Research

Past Reports

Historical coverage archive.

FRC Research
2 reports
Sep 27, 2023

EBITDA Improves Amid Product Launches and Aggressive Cost Cutting – FINAL REPORT

Mar 8, 2023

Ramping Up Revenue While Slashing Costs

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Elixinol Wellness Limited. Starting points for Elixinol Wellness Limited: EPS -AUD 0.0084, beta 2.18 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Elixinol Wellness Limited. Elixinol Wellness Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Elixinol Wellness Limited. Trailing twelve-month EPS for Elixinol Wellness Limited stands at -AUD 0.0084. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Elixinol Wellness Limited. Elixinol Wellness Limited has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold EXL.AX20 companies
Compare EXL.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
1AD.AXAdAlta LimitedHealthcareBiotechnology—
ANR.AXAnatara Lifesciences LtdHealthcareBiotechnology—
CAN.AXCann Group LimitedHealthcareDrug Manufacturers - Specialty & Generic—
CTQ.AXCareteq LimitedHealthcareMedical - Healthcare Information Services—
IBX.AXImagion Biosystems LimitedHealthcareMedical - Diagnostics & Research—
IVX.AXInvion LimitedHealthcareDrug Manufacturers - Specialty & Generic—
OAK.AXOakridge International LimitedHealthcareMedical - Healthcare Information Services—
OSX.AXOsteopore LimitedHealthcareMedical - Instruments & Supplies—
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
CBDHFHempfusion Wellness Inc.HealthcareOTC$1,635
CBDLCBD Life Sciences Inc.HealthcareOTC$375,394
CBDXCurative Biosciences, Inc.HealthcareOTC$51,578
CBDYTarget Group Inc.HealthcareOTC$863,836
CBGLCannabis Global, Inc.HealthcareOTC$28,410
CBIHCannabis Bioscience International Holdings, Inc.HealthcareOTC$5.2M
CBSTFThe Cannabist Company Holdings Inc.HealthcareNYSE$14.5M
CBWTFAuxly Cannabis Group Inc.HealthcareOTC$121.4M
CDVA.CNCordovaCann Corp.HealthcareCNQ$4.1M
CENBFCEN Biotech, Inc.HealthcareOTC$6,526
CGCCanopy Growth CorporationHealthcareNASDAQ$212.3M
CHALFChalice Brands Ltd.HealthcareOTC$6,660
Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Elixinol Wellness Limited.

EXL.AX AnalysisFair
Past
1
Growth
5
Health
3
Profit
1
Value
1